GLP-1 Medications and Hair Loss: Understanding Telogen Effluvium and What to Do

Nutritional Deficiencies and Hair Loss

Several specific nutrient deficiencies are known to cause or contribute to hair loss, and patients on GLP-1 therapy should be particularly attentive to them.

Iron deficiency is the most common nutritional cause of hair loss, particularly in women. Ferritin — the stored form of iron — should be checked in any patient experiencing hair shedding. Low ferritin impairs hair follicle cell division and can push follicles prematurely into telogen. Even low-normal ferritin (below 40-50 ng/mL) can cause hair loss in susceptible individuals.

Vitamin D deficiency is also strongly linked to hair loss. Vitamin D plays a role in the anagen phase initiation of the hair cycle. Deficiency is common in the general population and may be exacerbated by reduced sun exposure and dietary changes during GLP-1 therapy.

Zinc deficiency impairs protein synthesis and cell division, both of which are critical for hair growth. B-vitamin deficiencies — particularly biotin, B12, and folate — are also associated with hair shedding.

Protein intake deserves special attention. Hair is made primarily of keratin, a protein. When dietary protein is insufficient, the body deprioritizes non-essential protein synthesis, including keratin production in hair follicles. Patients on GLP-1 therapy who are eating significantly less food may inadvertently reduce protein intake below the level needed to maintain normal hair growth.

Other Contributing Factors

Beyond telogen effluvium from weight loss and nutritional deficiency, other factors can contribute to hair shedding during GLP-1 therapy. Thyroid dysfunction — both hypothyroidism and, less commonly, hyperthyroidism — causes hair loss, and thyroid function should be evaluated in any patient with significant hair shedding.

Iron deficiency anemia from menstrual blood loss in women, combined with reduced dietary iron intake, can create a particularly pronounced iron-deficiency state that manifests as severe hair shedding. Stress itself is also a trigger for telogen effluvium, and the physiological stress of significant metabolic change, even when positive, can contribute to shedding timing.

What to Do About GLP-1-Associated Hair Loss

The first and most important step is to have appropriate laboratory testing done. A comprehensive workup for hair loss during GLP-1 therapy should include a complete blood count (CBC), ferritin, iron, total iron-binding capacity (TIBC), vitamin D, zinc, thyroid function tests (TSH, free T4), and potentially B12 and folate. Without this data, treatment is guesswork.

Once deficiencies are identified, they should be corrected aggressively. Iron supplementation, vitamin D supplementation, zinc supplementation, and adequate protein intake are the foundational interventions. Working with a healthcare provider who understands hair loss and nutritional therapy is important — simply taking over-the-counter supplements without knowing your baseline levels may not address the specific deficiencies driving your hair loss.

Supporting Hair Regrowth

Hair regrowth after telogen effluvium requires patience. The follicles need to recover and restart the anagen phase, and hair grows slowly — approximately 0.5 inches per month on average. Visible improvement typically takes 3-6 months after the triggering event is identified and corrected.

During the recovery period, minimizing additional hair trauma helps preserve existing hair. This means avoiding tight hairstyles that pull on hair, minimizing heat styling, using gentle shampoo, and avoiding harsh chemical treatments. Scalp massage may increase blood flow to follicles and support recovery.

Some patients benefit from topical minoxidil, which prolongs the anagen phase and can accelerate regrowth. This should be discussed with a dermatologist or healthcare provider experienced in hair loss treatment, as minoxidil is not appropriate for all types of hair loss.

Preventing Hair Loss During GLP-1 Therapy

Prevention starts before hair loss begins. Patients beginning GLP-1 therapy who have a history of significant hair shedding or known nutritional deficiencies should be proactive about nutritional support.

Prioritize protein intake. Aim for at least 0.8-1.0 grams of protein per kilogram of body weight daily. For a person weighing 80 kg, this means 64-80 grams of protein per day. Protein should be distributed across meals, not consumed in a single large serving. Include protein sources at every meal — eggs, fish, poultry, lean meat, Greek yogurt, cottage cheese, legumes, and protein supplements as needed.

Consider a comprehensive multivitamin formulated for hair, skin, and nail health. Look for formulations containing iron, zinc, vitamin D, biotin, and B vitamins. However, do not start supplementation without first checking your levels — excess iron or other nutrients can cause problems of their own.

Track your symptoms in the PeptPro app, including hair shedding observations, energy levels, and dietary patterns. If you notice increased hair shedding, bring this information to your healthcare provider promptly so testing and intervention can begin without delay.

Hair loss during GLP-1 therapy is manageable, and in most cases, it resolves as the body adapts to its new weight and nutritional status. Do not stop your medication without consulting your healthcare provider — the benefits of GLP-1 therapy for metabolic health typically far outweigh the temporary inconvenience of hair shedding. Track your GLP-1 journey with PeptPro — https://peptpro.io

References

• EMA — Mounjaro (tirzepatida), EPAR
• Jastreboff et al., SURMOUNT-1 — NEJM (2022)
• OMS — Obesity and overweight, fact sheet